Lichen China
LICN
7 hedge funds and large institutions have $422K invested in Lichen China in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
1,269% more capital invested
Capital invested by funds: $30.8K → $422K (+$391K)
600% more funds holding
Funds holding: 1 → 7 (+6)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$159K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$78.5K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$48K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$33.6K |
| 5 |
HF
HRT Financial
New York
|
+$20K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.7K |
LICN Hedge Fund Activity: Q2 2024 in Review
7 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q2 2024, worth a combined $422K — up 1,269% from $30.8K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LICN positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Marex Group, opening a new position worth an estimated $159K. The largest seller was Susquehanna International Group, cutting an estimated $16.7K.
- 7 institutional investors held Lichen China (LICN) as of Q2 2024, up from 1 in Q1 2024.
- Funds reported $422K of Lichen China stock for Q2 2024, up 1,269% quarter-over-quarter.
- 6 funds opened new Lichen China positions in Q2 2024 and 0 closed out, a net change of +6 holders.
- The largest Lichen China buyer in Q2 2024 was Marex Group, an estimated $159K added.
- The largest Lichen China seller in Q2 2024 was Susquehanna International Group, an estimated $16.7K sold.
Based on aggregated 13F filings for Q2 2024.